August 21, 2024 03:04 PM EDTUpdated August 28, 09:30 AM
Pharma
FDA+

FDA warns hos­pi­tals against us­ing Pfiz­er's re­main­ing potas­si­um in­jec­tions for chil­dren

Zachary Brennan

Senior Editor

In an up­date to a warn­ing is­sued last year, the FDA said Wednes­day it re­mains con­cerned about the risk of alu­minum tox­i­c­i­ty as­so­ci­at­ed with a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Mod­er­na plans $1.1B in R&D and pro­gram cuts, de­lays break-even point to 2028

Sanofi buys in­to ra­dio­phar­ma­ceu­ti­cal field with $110M up­front, go­ing af­ter space held by No­var­tis

A new start­up wants to fight can­cer with 'off-the-shelf' gene ther­a­py, se­cur­ing $26M seed round

Sofinno­va’s Jim Healy on ‘more ra­tio­nal mar­ket’ as four biotech star­tups near their IPOs

J&J ex­pands Trem­fya in­to IBD with new FDA ap­proval

Ful­crum's Phase 3 for old GSK drug fails, stock sinks

A service from the Financial Times